rs17069506

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_176787.5(PIGN):​c.484A>G​(p.Lys162Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0438 in 1,587,798 control chromosomes in the GnomAD database, including 2,017 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. K162T) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.052 ( 251 hom., cov: 32)
Exomes 𝑓: 0.043 ( 1766 hom. )

Consequence

PIGN
NM_176787.5 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 0.0490

Publications

15 publications found
Variant links:
Genes affected
PIGN (HGNC:8967): (phosphatidylinositol glycan anchor biosynthesis class N) This gene encodes a protein that is involved in glycosylphosphatidylinositol (GPI)-anchor biosynthesis. The GPI-anchor is a glycolipid found on many blood cells and serves to anchor proteins to the cell surface. This protein is expressed in the endoplasmic reticulum and transfers phosphoethanolamine (EtNP) to the first mannose of the GPI anchor. Two alternatively spliced variants, which encode an identical isoform, have been reported. [provided by RefSeq, Jul 2008]
PIGN Gene-Disease associations (from GenCC):
  • multiple congenital anomalies-hypotonia-seizures syndrome 1
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P, Orphanet, ClinGen, PanelApp Australia
  • Fryns syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0016021132).
BP6
Variant 18-62154610-T-C is Benign according to our data. Variant chr18-62154610-T-C is described in ClinVar as Benign. ClinVar VariationId is 403309.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.0774 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PIGNNM_176787.5 linkc.484A>G p.Lys162Glu missense_variant Exon 7 of 31 ENST00000640252.2 NP_789744.1 O95427A0A024R2C3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PIGNENST00000640252.2 linkc.484A>G p.Lys162Glu missense_variant Exon 7 of 31 1 NM_176787.5 ENSP00000492233.1 O95427
PIGNENST00000400334.7 linkc.484A>G p.Lys162Glu missense_variant Exon 6 of 30 1 ENSP00000383188.2 O95427
PIGNENST00000638424.1 linkn.484A>G non_coding_transcript_exon_variant Exon 5 of 29 5 ENSP00000491963.1 A0A1W2PQZ1

Frequencies

GnomAD3 genomes
AF:
0.0516
AC:
7849
AN:
152054
Hom.:
251
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0741
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0424
Gnomad ASJ
AF:
0.0844
Gnomad EAS
AF:
0.0767
Gnomad SAS
AF:
0.0839
Gnomad FIN
AF:
0.0340
Gnomad MID
AF:
0.137
Gnomad NFE
AF:
0.0369
Gnomad OTH
AF:
0.0612
GnomAD2 exomes
AF:
0.0518
AC:
12836
AN:
247846
AF XY:
0.0537
show subpopulations
Gnomad AFR exome
AF:
0.0783
Gnomad AMR exome
AF:
0.0310
Gnomad ASJ exome
AF:
0.0864
Gnomad EAS exome
AF:
0.0797
Gnomad FIN exome
AF:
0.0347
Gnomad NFE exome
AF:
0.0398
Gnomad OTH exome
AF:
0.0584
GnomAD4 exome
AF:
0.0429
AC:
61639
AN:
1435626
Hom.:
1766
Cov.:
25
AF XY:
0.0448
AC XY:
32040
AN XY:
715826
show subpopulations
African (AFR)
AF:
0.0792
AC:
2596
AN:
32768
American (AMR)
AF:
0.0321
AC:
1430
AN:
44566
Ashkenazi Jewish (ASJ)
AF:
0.0866
AC:
2247
AN:
25946
East Asian (EAS)
AF:
0.0753
AC:
2971
AN:
39440
South Asian (SAS)
AF:
0.0884
AC:
7539
AN:
85268
European-Finnish (FIN)
AF:
0.0339
AC:
1789
AN:
52776
Middle Eastern (MID)
AF:
0.144
AC:
822
AN:
5718
European-Non Finnish (NFE)
AF:
0.0359
AC:
39143
AN:
1089692
Other (OTH)
AF:
0.0522
AC:
3102
AN:
59452
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.462
Heterozygous variant carriers
0
2524
5048
7571
10095
12619
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1562
3124
4686
6248
7810
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0517
AC:
7866
AN:
152172
Hom.:
251
Cov.:
32
AF XY:
0.0526
AC XY:
3916
AN XY:
74398
show subpopulations
African (AFR)
AF:
0.0742
AC:
3079
AN:
41494
American (AMR)
AF:
0.0423
AC:
647
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.0844
AC:
293
AN:
3470
East Asian (EAS)
AF:
0.0770
AC:
400
AN:
5192
South Asian (SAS)
AF:
0.0841
AC:
405
AN:
4814
European-Finnish (FIN)
AF:
0.0340
AC:
361
AN:
10616
Middle Eastern (MID)
AF:
0.140
AC:
41
AN:
292
European-Non Finnish (NFE)
AF:
0.0369
AC:
2508
AN:
67974
Other (OTH)
AF:
0.0624
AC:
132
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
374
748
1123
1497
1871
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
96
192
288
384
480
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0430
Hom.:
509
Bravo
AF:
0.0526
TwinsUK
AF:
0.0361
AC:
134
ALSPAC
AF:
0.0384
AC:
148
ESP6500AA
AF:
0.0745
AC:
273
ESP6500EA
AF:
0.0405
AC:
331
ExAC
AF:
0.0538
AC:
6503
Asia WGS
AF:
0.0710
AC:
246
AN:
3476
EpiCase
AF:
0.0451
EpiControl
AF:
0.0456

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Jul 05, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
Mar 29, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: MAF -

Inborn genetic diseases Benign:1
Apr 07, 2016
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Multiple congenital anomalies-hypotonia-seizures syndrome 1 Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.052
BayesDel_addAF
Benign
-0.65
T
BayesDel_noAF
Benign
-0.63
CADD
Benign
0.11
DANN
Benign
0.39
DEOGEN2
Benign
0.012
T;.;T;T;T;.;.;.;.;T;.;.;T;.;T;.;.;.;.;.;.;.;.;.;T;T;T
Eigen
Benign
-1.4
Eigen_PC
Benign
-1.3
FATHMM_MKL
Benign
0.014
N
LIST_S2
Benign
0.64
.;.;.;.;.;.;T;.;T;.;T;T;.;T;T;T;T;.;.;T;T;T;T;T;.;T;T
MetaRNN
Benign
0.0016
T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T
MetaSVM
Benign
-0.99
T
MutationAssessor
Benign
-3.3
N;.;N;N;N;.;.;.;.;N;.;.;N;.;N;.;.;.;.;.;.;.;.;.;.;.;.
PhyloP100
0.049
PrimateAI
Benign
0.21
T
PROVEAN
Benign
3.0
.;.;.;N;.;.;.;.;.;N;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.
REVEL
Benign
0.13
Sift
Benign
1.0
.;.;.;T;.;.;.;.;.;T;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.
Sift4G
Benign
1.0
.;.;.;T;.;.;.;.;.;T;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;T
Polyphen
0.0
B;.;B;B;B;.;.;.;.;B;.;.;B;.;B;.;.;.;.;.;.;.;.;.;.;.;.
Vest4
0.017
MPC
0.027
ClinPred
0.0042
T
GERP RS
-2.9
PromoterAI
0.039
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.050
gMVP
0.23
Mutation Taster
=98/2
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs17069506; hg19: chr18-59821843; COSMIC: COSV62947565; COSMIC: COSV62947565; API